Literature DB >> 7910962

Involvement of human muscle acetylcholine receptor alpha-subunit gene (CHRNA) in susceptibility to myasthenia gravis.

H J Garchon1, F Djabiri, J P Viard, P Gajdos, J F Bach.   

Abstract

The muscle acetylcholine receptor is the major target of the autoimmune response in generalized myasthenia gravis. To investigate the role of the gene encoding the alpha subunit of the receptor (CHRNA), two stable polymorphic d[(GT).(CA)]dinucleotide repeats, designated HB and BB, were characterized within the first intron of CHRNA. The HB*14 allele conferred a relative risk for myasthenia gravis of 2.5 in 81 unrelated patients compared with 100 control subjects. Very significantly, family analysis based on haplotype segregation data indicated that parental haplotypes associated with HB*14 always segregated to the child with myasthenia gravis (P < 0.0002 for the comparison with the transmission of haplotypes not bearing HB*14), whereas their transmission to unaffected siblings was equilibrated. Myasthenia gravis patients also showed a high frequency of microsatellite variants unseen in controls. These findings implicate the CHRNA in susceptibility to myasthenia gravis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910962      PMCID: PMC43849          DOI: 10.1073/pnas.91.11.4668

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

Review 2.  Functional architecture of the nicotinic acetylcholine receptor: from electric organ to brain.

Authors:  J L Galzi; F Revah; A Bessis; J P Changeux
Journal:  Annu Rev Pharmacol Toxicol       Date:  1991       Impact factor: 13.820

3.  Genetic factors in myasthenia gravis: a family study.

Authors:  L Kerzin-Storrar; R A Metcalfe; P A Dyer; G Kowalska; I Ferguson; R Harris
Journal:  Neurology       Date:  1988-01       Impact factor: 9.910

4.  T-cell receptor V alpha and C alpha alleles associated with multiple and myasthenia gravis.

Authors:  J R Oksenberg; M Sherritt; A B Begovich; H A Erlich; C C Bernard; L L Cavalli-Sforza; L Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

5.  The haplotype-relative-risk (HRR) method for analysis of association in nuclear families.

Authors:  M Knapp; S A Seuchter; M P Baur
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

6.  d(TG)n.d(CA)n sequences upstream of the rat prolactin gene form Z-DNA and inhibit gene transcription.

Authors:  L H Naylor; E M Clark
Journal:  Nucleic Acids Res       Date:  1990-03-25       Impact factor: 16.971

Review 7.  Myasthenia gravis: recognition of a human autoantigen at the molecular level.

Authors:  M P Protti; A A Manfredi; R M Horton; M Bellone; B M Conti-Tronconi
Journal:  Immunol Today       Date:  1993-07

8.  Anti-idiotypic antibodies, acetylcholine receptor antibodies and disturbed neuromuscular function in healthy relatives to patients with myasthenia gravis.

Authors:  A K Lefvert; R Pirskanen; E Svanborg
Journal:  J Neuroimmunol       Date:  1985-07       Impact factor: 3.478

9.  Neonatal myasthenia gravis. Anti-acetylcholine receptor antibodies in the amniotic fluid.

Authors:  E Morel; J F Bach; M L Briard; J P Aubry
Journal:  J Neuroimmunol       Date:  1984-08       Impact factor: 3.478

10.  HLA-DQ beta-chain polymorphism linked to myasthenia gravis.

Authors:  J Bell; L Rassenti; S Smoot; K Smith; C Newby; R Hohlfeld; K Toyka; H McDevitt; L Steinman
Journal:  Lancet       Date:  1986-05-10       Impact factor: 79.321

View more
  5 in total

Review 1.  Myasthenia gravis as a prototype autoimmune receptor disease.

Authors:  A C Hoedemaekers; P J van Breda Vriesman; M H De Baets
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

2.  beta2-adrenergic receptor gene polymorphisms in myasthenia gravis (MG).

Authors:  B Y Xu; D Huang; R Pirskanen; A K Lefvert
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

3.  A cell atlas of human thymic development defines T cell repertoire formation.

Authors:  Jong-Eun Park; Rachel A Botting; Cecilia Domínguez Conde; Dorin-Mirel Popescu; Marieke Lavaert; Daniel J Kunz; Issac Goh; Emily Stephenson; Roberta Ragazzini; Elizabeth Tuck; Anna Wilbrey-Clark; Kenny Roberts; Veronika R Kedlian; John R Ferdinand; Xiaoling He; Simone Webb; Daniel Maunder; Niels Vandamme; Krishnaa T Mahbubani; Krzysztof Polanski; Lira Mamanova; Liam Bolt; David Crossland; Fabrizio de Rita; Andrew Fuller; Andrew Filby; Gary Reynolds; David Dixon; Kourosh Saeb-Parsy; Steven Lisgo; Deborah Henderson; Roser Vento-Tormo; Omer A Bayraktar; Roger A Barker; Kerstin B Meyer; Yvan Saeys; Paola Bonfanti; Sam Behjati; Menna R Clatworthy; Tom Taghon; Muzlifah Haniffa; Sarah A Teichmann
Journal:  Science       Date:  2020-02-21       Impact factor: 47.728

4.  Whole-genome analysis in Korean patients with autoimmune myasthenia gravis.

Authors:  Sang-Jun Na; Ji Hyun Lee; So Won Kim; Dae-Seong Kim; Eun Hee Shon; Hyung Jun Park; Ha Young Shin; Seung Min Kim; Young-Chul Choi
Journal:  Yonsei Med J       Date:  2014-04-01       Impact factor: 2.759

5.  Nicotinic acetylcholine receptor subunit variants are associated with blood pressure; findings in the Old Order Amish and replication in the Framingham Heart Study.

Authors:  Patrick F McArdle; Sue Rutherford; Braxton D Mitchell; Coleen M Damcott; Ying Wang; Vasan Ramachandran; Sandy Ott; Yen-Pei C Chang; Daniel Levy; Nanette Steinle
Journal:  BMC Med Genet       Date:  2008-07-14       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.